Suzhou Docosu Technology Co., Ltd – Trademark Portfolio
Entity Type: 99
Suzhou Docosu Technology Co., Ltd owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CRWER, AUXUOR, BARBUB, BSTELA, and EFSEVE. Of these, 6 are registered. The portfolio spans 4 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 8 (Hand Tools). Headquartered in Suzhou Jiangsu.
Rm.1006, 10F, Bldg.A,Dushu Lake Alliance
No.27, Xinfa Road,Suzhou Industrial Park
Suzhou Jiangsu 215000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Suzhou Docosu Technology Co., Ltd's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Suzhou Docosu Technology Co., Ltd have?
Suzhou Docosu Technology Co., Ltd has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Suzhou Docosu Technology Co., Ltd file in?
Suzhou Docosu Technology Co., Ltd files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 8 (Hand Tools), Class 7 (Machinery), Class 12 (Vehicles). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Suzhou Docosu Technology Co., Ltd's most well-known trademarks?
Suzhou Docosu Technology Co., Ltd's registered trademark portfolio includes well-known marks such as CRWER, AUXUOR, BARBUB, BSTELA, and EFSEVE. These are among 6 currently registered trademarks in the portfolio.
What is Suzhou Docosu Technology Co., Ltd's trademark registration success rate?
Suzhou Docosu Technology Co., Ltd has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.